Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I. Epidemiology of glioblastoma multiforme-literature review. Cancers. 2022;14(10):2412. https://doi.org/10.3390/cancers14102412.

Article  PubMed  PubMed Central  Google Scholar 

Iturrioz-Rodríguez N, De Pasquale D, Fiaschi P, Ciofani G. Discrimination of glioma patient-derived cells from healthy astrocytes by exploiting Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2022;269:120773. https://doi.org/10.1016/j.saa.2021.120773.

Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764–72. https://doi.org/10.1158/1078-0432.CCR-12-3002.

Article  CAS  PubMed  Google Scholar 

Jusue-Torres I, Prabhu VC, Jones GA. Dandy’s hemispherectomies: historical vignette. J Neurosurg. 2021;135(6):1836–42. https://doi.org/10.3171/2020.9.JNS202824.

Article  PubMed  Google Scholar 

Lara-Velazquez M, Al-Kharboosh R, Jeanneret S, Vazquez-Ramos C, Mahato D, Tavanaiepour D, Rahmathulla G, Quinones-Hinojosa A. Advances in brain tumor surgery for glioblastoma in adults. Brain Sci. 2017;7(12):166. https://doi.org/10.3390/brainsci7120166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seker-Polat F, Pinarbasi Degirmenci N, Solaroglu I, Bagci-Onder T. Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives. Cancers (Basel). 2022;14(2):443. https://doi.org/10.3390/cancers14020443.

Article  CAS  PubMed  Google Scholar 

Kondziolka D, Dade Lunsford L. The role of stereotactic biopsy in the management of gliomas. J Neurooncol. 1999;42:205–13. https://doi.org/10.1023/A:1006105415194.

Article  CAS  PubMed  Google Scholar 

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190–8. https://doi.org/10.3171/jns.2001.95.2.0190.

Article  CAS  PubMed  Google Scholar 

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401. https://doi.org/10.1016/S1470-2045(06)70665-9.

Article  CAS  PubMed  Google Scholar 

Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3–8. https://doi.org/10.3171/2011.2.jns10998.

Article  PubMed  Google Scholar 

Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC, German Glioma N. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Ann Oncol. 2013;24:3117–23. https://doi.org/10.1093/annonc/mdt38.

Article  PubMed  Google Scholar 

Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen CC. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg. 2014;120(1):31–9. https://doi.org/10.3171/2013.9.JNS13877.

Article  PubMed  Google Scholar 

Awad AW, Karsy M, Sanai N, et al. Impact of removed tumor volume and location on patient outcome in glioblastoma. J Neurooncol. 2017;135:161–71. https://doi.org/10.1007/s11060-017-2562-1.

Article  PubMed  Google Scholar 

Cui M, Chen H, Sun G, et al. Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum. Acta Neurochir. 2022;164:689–702. https://doi.org/10.1007/s00701-021-05008-6.

Article  PubMed  Google Scholar 

Mohammed S, Dinesan M, Ajayakumar T. Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Rep Pract Oncol Radiother. 2022;27(6):1026–36. https://doi.org/10.5603/RPOR.a2022.0113.

Article  PubMed  PubMed Central  Google Scholar 

Vivas-Buitrago T, Domingo RA, Tripathi S, De Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sabsevitz DS, Bendok BR, Sherman W, Parney IF, Jentoft ME, Middlebrooks EH, Meyer FB, Chaichana KL, Quinones-Hinojosa A. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg. 2021;136(1):1–8. https://doi.org/10.3171/2020.10.JNS203366. The study reported improvement in OS after supramarginal resection regardless of age. A key study since age is one of the many factors that influence survival in GBM resection.

Article  PubMed  PubMed Central  Google Scholar 

Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Clerici E, Rossi M, Scorsetti M, Bello L. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neuro-Oncol. 2017;135:129–39.

Article  Google Scholar 

Shah AH, Mahavadi A, Di L, et al. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection. J Neurooncol. 2020;148:501–8. https://doi.org/10.1007/s11060-020-03541-5\.

Article  PubMed  PubMed Central  Google Scholar 

Khalafallah AM, Rakovec M, Bettegowda C, Jackson CM, Gallia GL, Weingart JD, Lim M, Esquenazi Y, Zacharia BE, Goldschmidt E, Ziu M, Ivan ME, Venteicher AS, Nduom EK, Mamelak AN, Chu RM, Yu JS, Sheehan JP, Nahed BV, Carter BS, Berger MS, Sawaya R, Mukherjee D. A crowdsourced consensus on supratotal resection versus gross total resection for anatomically distinct primary glioblastoma. Neurosurgery. 2021;89(4):712–9. https://doi.org/10.1093/neuros/nyab257. The study surveyed neurosurgeons to identify the understanding of the definition of supramaximal resection. Currently, there has been no consensus on supramarginal vs supramaximal, and this paper surveyed the current landscape.

Article  PubMed  PubMed Central  Google Scholar 

Molinaro AM, Hervey-Jumper S, Morshed RA, et al. Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma [published correction appears in JAMA Oncol. 2020 Mar 1;6(3):444]. JAMA Oncol. 2020;6(4):495–503. https://doi.org/10.1001/jamaoncol.2019.6143. Compared maximal EOR of CE tumors across different age groups and found a difference in survival between younger and older populations.

Article  PubMed  PubMed Central  Google Scholar 

Tripathi S, Vivas-Buitrago T, Domingo RA, Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sherman W, Gupta V, Middlebrooks EH, Sabsevitz DS, Porter AB, Uhm JH, Bendok BR, Parney I, Meyer FB, Chaichana KL, Swanson KR, Quiñones-Hinojosa A. IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model. J Neurosurg. 2021;136(6):1567–75. https://doi.org/10.3171/2021.6.JNS21925. Investigated the efficacy of supramarginal resection depending on tumor differences and found a difference in survival when comparing nodular tumors vs moderately diffuse vs highly diffuse tumors.

Article  PubMed  PubMed Central  Google Scholar 

Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM 2nd, Bruce JN, Rostomily RC, Canoll P, Swanson KR. Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas. PLoS ONE. 2014;9(10):e99057. https://doi.org/10.1371/journal.pone.0099057.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui M, Chen H, Sun G, et al. Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum. Acta Neurochir. 2022;164:689–702. https://doi.org/10.1007/s00701-021-05008-6.

Article  PubMed  Google Scholar 

Altieri R, Certo F, Pacella D, et al. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection. J Neurooncol. 2023;162:417–23. https://doi.org/10.1007/s11060-023-04305-7. Utilized 11[C]-MET-PET to evaluate metabolic activity of tumor beyond FLAIR imaging, which showed the invasive nature of GBM tumor cells.

Article  CAS  PubMed  Google Scholar 

Otsuji R, Hata N, Funakoshi Y, Kuga D, Togao O, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Sako A, Kikuchi K, Yoshitake T, Yamamoto H, Mizoguchi M, Yoshimoto K. Supramaximal resection can prolong the survival of patients with cortical glioblastoma: a volumetric study. Neurol Med Chir (Tokyo). 2023;63(8):364–374. https://doi.org/10.2176/jns-nmc.2022-0351. Provided a cutoff for supramaximal resection (30% beyond CE), but highlighted differences in OS depending on tumor location.

Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Weller M, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Berger MS, Chang SM, van den Bent M, Tonn JC. Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group. Neuro Oncol. 2023;25(5):940–54. https://doi.org/10.1093/neuonc/noac193. One of the largest recent retrospective studies that aimed to provide a clear definition of supramaximal resection to avoid ambiguity.

Article  CAS  PubMed  Google Scholar